BETH ISRAEL DEACONESS MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1896-01-01

Employees: -

Market Cap: -

Website: https://www.bidmc.org/

Clinical Trials

Early Functional Outcomes After Closed Reduction With Pinning Versus Open Reduction Internal Fixation of Wrist Fractures

Not Applicable

Completed

Conditions: Wrist Fractures

Interventions: Procedure: CRPP
Procedure: ORIF

First Posted Date: 2009-01-26

Last Posted Date: 2017-02-07

Lead Sponsor: Beth Israel Deaconess Medical Center

Registration Number: NCT00828685

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma

Phase 2

Completed

Conditions: Renal Cancer
Renal Cell Carcinoma

Interventions: Drug: Everolimus

First Posted Date: 2009-01-22

Last Posted Date: 2021-02-24

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 25

Registration Number: NCT00827359

Locations: 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized Hepatocellular Cancer

Phase 2

Completed

Conditions: Hepatocellular Cancer

Interventions: Drug: Sorafenib
Procedure: radiofrequency ablation

First Posted Date: 2008-12-23

Last Posted Date: 2023-06-13

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 20

Registration Number: NCT00813293

Locations: 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

CyberKnife for Unresectable Renal Tumors

Not Applicable

Completed

Conditions: Renal Cancer

Interventions: Radiation: Stereotactic radiation
Device: CyberKnife Robotic Radiosurgery System

First Posted Date: 2008-12-11

Last Posted Date: 2017-03-21

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 17

Registration Number: NCT00807339

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Primary Tumor Harvest for the Purpose of Possible Use in a Future Clinical Trial in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Not Applicable

Completed

Conditions: Fallopian Tube Cancer
Peritoneal Cancer
Ovarian Cancer

Interventions: Procedure: Tumor collection

First Posted Date: 2008-12-03

Last Posted Date: 2020-09-10

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 100

Registration Number: NCT00801320

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Brigham & Women's Hospital, Boston, Massachusetts, United States
🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States

and more 1 locations

Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod

Phase 2

Active, not recruiting

Conditions: Ovarian Cancer
Primary Peritoneal Cancer
Fallopian Tube Cancer

Interventions: Drug: GM-CSF
Biological: Dendritic Cell/Tumor Fusion Vaccine
Drug: imiquimod

First Posted Date: 2008-11-27

Last Posted Date: 2024-06-11

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 23

Registration Number: NCT00799110

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Brigham & Women's Hospital, Boston, Massachusetts, United States

and more 1 locations

Quality of Life Therapy for Adults With Hepatitis C Virus and Cirrhosis Awaiting Liver Transplantation

Not Applicable

Completed

Conditions: Chronic HCV

Interventions: Behavioral: Quality of Life Therapy
Behavioral: Supportive Therapy

First Posted Date: 2008-11-20

Last Posted Date: 2017-03-15

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 75

Registration Number: NCT00794911

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Endothelium in Severe Sepsis

Completed

Conditions: Severe Sepsis
Septic Shock
Sepsis

Interventions: Diagnostic Test: Blood Collection and Assays

First Posted Date: 2008-11-19

Last Posted Date: 2024-10-29

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 910

Registration Number: NCT00793442

Locations: 🇺🇸
North Shore University Hospital, Manhasset, New York, United States
🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

and more 4 locations

Non-invasive Brain Stimulation and Occupational Therapy To Enhance Stroke Recovery

Not Applicable

Completed

Conditions: Acute Stroke
Apoplexy
Acute Cerebrovascular Accident
Stroke
Cerebrovascular Accident
CVA

Interventions: Device: Sham Transcranial Direct Current Stimulation
Device: Real Transcranial Direct Current Stimulation

First Posted Date: 2008-11-18

Last Posted Date: 2018-06-04

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 20

Registration Number: NCT00792428

Locations: 🇺🇸
Beth Israel Deaconess Medical Center / Harvard Medical School, Boston, Massachusetts, United States

Alcohol and Atherosclerosis Pilot Study

Not Applicable

Completed

Conditions: Atherosclerosis

Interventions: Other: Ethanol-free beverage
Other: ethanol

First Posted Date: 2008-11-06

Last Posted Date: 2016-01-12

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 39

Registration Number: NCT00786279

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy